Scholarly Index
Qing Ye
Virginia Tech; 21,413 total citations; 598 total publications; best world rank #49
Virginia Tech
21,413Total citations
598Total publications
57H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 146 | US 37 | 99.19 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 251 | US 93 | 99.01 |
| SARS-CoV-2 detection and testing | Lifetime | 158 | US 47 | 96.59 |
| Lymphatic Disorders and Treatments | Lifetime | 485 | US 203 | 67.93 |
| COVID-19 Clinical Research Studies | 2021-2025 | 94 | US 31 | 99.44 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 112 | US 40 | 99.44 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 49 | US 16 | 98.74 |
| SARS-CoV-2 detection and testing | 2021-2025 | 82 | US 22 | 97.59 |
| Respiratory viral infections research | 2021-2025 | 107 | US 51 | 97.64 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 317 | US 82 | 95.59 |
| vaccines and immunoinformatics approaches | 2021-2025 | 125 | US 29 | 93.74 |
| Esophageal Cancer Research and Treatment | 2021-2025 | 999 | US 154 | 86.64 |